Sign Up to like & get
recommendations!
1
Published in 2017 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2017.06.003
Abstract: Epidermal growth factor receptor (EGFR) mutations have been used as the strongest predictor of effectiveness of treatment with EGFR tyrosine kinase inhibitors (TKIs). Three most common EGFR mutations (L858R, exon 19 deletion, and T790M) are…
read more here.
Keywords:
egfr mutations;
factor receptor;
growth factor;
picodroplet digital ... See more keywords